Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Health Care Select Sector SPDR Fund (XLV) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance

Health Care Select Sector SPDR FundTrade
YieldMax Magnificent 7 Fund of Option Income ETFsTrade

Price performance (Past 24H)

Key statistics

Health Care Select Sector SPDR Fund vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Health Care Select Sector SPDR Fund trades at $160.19, while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.64. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.

XLVYMAG
52-Week High
$164.48$15.98
52-Week Low
$129.01$11.00
Sector
Income / Options Overlay

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Health Care Select Sector SPDR Fund

XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.

XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.

YieldMax Magnificent 7 Fund of Option Income ETFs

YMAG trades at $11.63, up 0.17% with a bearish technical signal from moving averages. The ETF provides weekly distributions, recently ranging from $0.07 to $0.40 per share, targeting income through covered calls on Magnificent Seven stocks. Key financial ratios are unavailable, limiting fundamental assessment. Recent news highlights distribution announcements and strategy discussions amid mixed sentiment regarding its performance versus peers.

Outlook hinges on volatility monetization via options, offering high yield but facing NAV decay risks. Investment appeal lies in income generation during range-bound markets, though underperformance in rising equity environments and high expenses pose challenges. Risks include dependency on underlying stock volatility and competitive ETF pressure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV

About YieldMax Magnificent 7 Fund of Option Income ETFs

YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.

Read more on YMAG